Speeches & Presentations

  • Toronto, Indianapolis, and the Breakthrough that Saved Millions of Lives (And How Similar Collaborations Can Defeat the Chronic-Disease Scourges of the 21st Century)
    Remarks at the Economic Club of Canada, Toronto, Canada
    January 19, 2016
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer—Eli Lilly and Company
  • Bold Leadership in Uncertain Times
    Keynote Address, Indiana Chamber and Butler Business Accelerator ExecConnect Series, Indianapolis, Indiana
    June 10, 2015
    Enrique Conterno, Sr. Vice President and President, Diabetes Business Unit — Eli Lilly and Company
  • Continuous Innovation Against Cancer
    CED Life Science Conference, Raleigh, North Carolina
    March 3, 2015
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • The Role of Biopharmaceutical Companies in Global Health
    Richard G. Lugar Franciscan Center for Global Studies Speaker Series, Indianapolis, Indiana
    January 20, 2015
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • Collaboration, Innovation, Opportunity
    Remarks at Purdue University, West Lafayette, Indiana
    September 25, 2014
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • How a Corporation Should Think About Social Responsibility
    S.K. Lacy Class, Indianapolis, Indiana
    March 4, 2014
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • STEM Saves Lives
    STEM Saves Lives Event, Sponsored by PhRMA and U.S. News & World Report, Washington, DC
    January 22, 2014
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • Translating Science Into Hope
    PhRMA Annual Meeting, Chairman’s Welcome , San Diego, California
    April 11, 2013
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • Closing Remarks
    PhRMA Annual Meeting , San Diego, California
    April 11, 2013
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • Leadership in Uncertain Times
    Remarks to Leaders from Lilly Japan Affiliate and Kobe Business Community , Kobe, Japan
    January 28, 2013
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • An Ecosystem for Pharmaceutical Innovation
    2012 International Summit for Pharma Innovation , Beijing, China
    November 30, 2012
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • President’s Inaugural Address
    International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) 26th IFPMA Assembly, Geneva, Switzerland
    October 31, 2012
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • Indiana Life Sciences Summit
    Indiana at the (Bio)Crossroads, Indianapolis, Indiana
    October 23, 2012
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • Financial Times U.S. Healthcare and Life Sciences Conference
    Innovation: The Long Run, New York City, New York
    June 6, 2012
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • Commencement Address University of Indianapolis, Class of 2012
    , Indianapolis, Indiana
    May 5, 2012
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer Eli Lilly and Company
  • PhRMA Inaugural Address
    , Boston Massachusetts
    April 13, 2012
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer — Eli Lilly and Company
  • American Chamber of Commerce Pharma Committee
    Medical Innovation: The Link Between Health and Economic Growth, Seoul, Korea
    March 13, 2012
    John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer Eli Lilly and Company
Please enable your browser's JavaScript setting in order to access this site